Certificate of Suitability (CEP) for the API Thiocolchicosides has been granted. Chereso is among the top companies to receive the CEP from the European Directorate for the Quality of Medicines (EDQM). With our expanded manufacturing capacities, this certificate makes us a reliable partner to provide the product with credibility.
We are delighted and proud to announce that our product Reserpine (Rauwolfia Vomitoria) has been granted DMF in China. DMF No.: JYMS1700007
It is an immense pleasure to share this news that our Research Scholar – Ms. Manpreet Kaur working under the Prime Minister Research Fellowship (an initiative of FICCI and SERB) with our company on the topic “Biochemical Characterization of Euryhaline Microalgal Strina for Bioactive Metabolites” under the guidance of Dr Surekha Bhatia, Senior Biochemist, department…
CHERESO (Chemical Resources), the manufacturer of Alpha Yohimbine/Rauwolscine and other innovative ingredients for various health applications like Polycystic Ovary Syndrome (PCOS), Prostate, Glucose Levels, Metabolism, and Men’s Health, has been granted U.S. Patent No. 10,730,869 B2 under the title: “Process for Extracting Alpha Yohimbine (Rauwolscine) from Rauwolfia Species” Alpha Yohimbine/Rauwolscine is being manufactured by CHERESO…
We have been granted the following Patents for ‘A Single herb extract for the treatment of PCOS (Polycystic Ovarian Syndrome)’ Country Patent No. FRANCE & POLAND EP3233100B1 GERMANY 602015070972.1 ITALY 502021000080333 CHINA CN109152729B
We are happy to announce that we have been granted a patent for our innovation – ‘Process for Extracting Alpha Yohimbine (Rauwolscine) from Rauwolfia Species’ in the United States. MORE TO COME!
Grecobe Cup girls Senior League Cup Knock out Cricket 20.20 Competition will be held from January 4 to January 7 at Tau Devi Lal Cricket Stadium, Sector 3, Panchkula. The trophy was unveiled today at Hotel Red Bishop, Panchkula by Shri Gyan Chand Gupta, Honorable Speaker Haryana Vidhan Sabha & Sh.Pawan Goel, the Director of…
Researchers in the United States, Canada & Europe are testing Colchicine on approximately 6,000 participants for a period of 30 days. The trial is to find out whether short-term treatment with colchicine will reduce lung complications and the rate of death in COVID-19 patients. Colchicine is thought to decrease the ‘cytokine storm’ or inflammation that…
We often take “thank you,” “please,” and “you’re welcome” for granted. Let’s mean what we say this Christmas. Show some appreciation to your parents, wife, family, relatives, friends, officemates, employees, business partners, vendors/providers, and the people who made a difference in your life this year. Let us start first by thanking you for supporting a…
We Will exhibit at CPhI Japan which will be held at Tokyo Big Sight, Koto in March 2022. It will be 3-days event organized by UBM EMEA. You may please visit us at our stand( will update the stand no. soon)